Prognostic impact of CD133 expression in Endometrial Cancer Patients
Abstract To assess the impact of CD133 expression on the prognosis of endometrioid endometrial carcinoma (EEC). We retrospectively assessed CD133 expression in tissue microarray of 116 surgically treated FIGO I-III EEC. Tumors with ≥10% of CD133-expressing cells were considered CD133-positive (CD133...
Guardado en:
Autores principales: | G. Mancebo, J. M. Sole-Sedeno, O. Pino, E. Miralpeix, S. Mojal, L. Garrigos, B. Lloveras, P. Navarro, J. Gibert, M. Lorenzo, I. Aran, R. Carreras, F. Alameda |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3ddb17437f2a4cff903814dfb8c2706d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133+ osteosarcoma cancer stem cells
por: Ni MZ, et al.
Publicado: (2015) -
Quantum dots affect expression of CD133 surface antigen in melanoma cells
por: Steponkiene S, et al.
Publicado: (2011) -
CD44/CD133-Positive Colorectal Cancer Stem Cells are Sensitive to Trifluridine Exposure
por: Kenta Tsunekuni, et al.
Publicado: (2019) -
Acta No. 133
por: Banco Central de Chile
Publicado: (2019) -
CEPAL Review no. 133
Publicado: (2021)